Body Chat Podcast · Dr. Stephen Nedd: Chiropractic Physician | Educator | Sharing Over 25 Years of Knowledge on Alternative Health Solutions & Ron Nedd - Author, Innovator, Podcast Host & Realtor®

Episode 294: Diving into Methylene Blue

·28 min·1 clip
Methylene blue is a drug from 1876, not a supplement, and it became the first synthetic drug used for malaria.
1. Body Chat Podcast episode 294 focuses on methylene blue as an “outside-the-box” health topic. 2. Ron Nedd hosts with Dr. Steven Nedd, his brother, who runs a chiropractic practice in Clearwater, Florida, and answers the episode’s practical questions. 3. The episode asks what methylene blue is, how it works, and why it has drawn interest in natural health and biohacking. 4. Dr. Steven Nedd says methylene blue was developed as a dye in 1876 and later used in medicine in 1890 for malaria. 5. He says the compound is the parent molecular compound for hydroxychloroquine and chloroquine and has also been used to derive other drugs. 6. He says hospitals keep methylene blue because it is the only known antidote for carbon monoxide poisoning, cyanide, and methemoglobinemia. 7. Ron Nedd defines biohacking through Dr. Robert Malone as a DIY method to achieve optimal health. 8. The biohacking examples named in the episode include intermittent fasting, high-intensity interval training, organic home gardening, CGMs, wearable monitors, and Function blood testing. 9. Dr. Steven Nedd explains that methylene blue supports mitochondrial energy production and ATP. 10. He says the compound can cycle between donating and accepting electrons indefinitely, which he describes as improving mitochondrial efficiency. 11. He says low-dose methylene blue can increase ATP production in four ways, including a red-blood-cell pathway. 12. He explains that methylene blue changes the heme configuration in hemoglobin, which improves oxygen carrying capacity and helps with methemoglobinemia. 13. The episode cites a 2018 systematic review of 22 articles and 21 studies involving 1,504 malaria patients. 14. It also cites a November 2019 Alzheimer’s disease journal study on hydromethylthionine, described as showing cognitive improvement over 65 weeks. 15. Dr. Steven Nedd says other cited uses include fatty liver disease, inflammation, EMF exposure, bone health, and heart-attack tissue damage. 16. He also says methylene blue has been used for shock, iphosomide-induced encephalopathy, urinary tract infections, and COVID-related breathing issues. 17. The tone is instructional and conversational, with Ron Nedd asking short follow-up questions and Dr. Steven Nedd answering at length. 18. The format stays organized around definitions, mechanisms, studies, dosing, risks, and sourcing advice. 19. Listeners interested in biohacking, mitochondrial health, and medication repurposing may find it useful. 20. Listeners looking for a neutral overview without drug-specific discussion may skip it.
Listen to the show on